Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Head-and-neck Squamous Cell Carcinoma (HNSCC)
100%
Gene Signature
100%
Brain Metastases
100%
MAP2K1
100%
PD-L1 Expression
100%
Human Papillomavirus
100%
Foundation Medicine
50%
Tumor
25%
Tumor Protein p53 (TP53)
25%
Oropharynx
25%
PIK3CA
25%
Proximity Ligation
25%
Next-generation Sequencing
12%
CD8+
12%
Median Overall Survival
12%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
12%
Severe Complications
12%
FoxP3+ Cells
12%
Molecular Characteristics
12%
Former Smokers
12%
Gene Set Enrichment Analysis
12%
Molecular Alterations
12%
Immune Cells
12%
Structural Rearrangement
12%
Immunogenicity
12%
Low Density
12%
Immunofluorescence
12%
TSC1
12%
Programmed Death-ligand 1 (PD-L1)
12%
Inactivating mutation
12%
Academic Center
12%
P16+
12%
KMT2A
12%
Local Sample
12%
Targetable
12%
Metastasis Diagnosis
12%
PD-L1 Combined Positive Score
12%
Biochemistry, Genetics and Molecular Biology
Wart Virus
100%
Gene Signature
100%
PD-L1
100%
MAP2K2
100%
Overall Survival
20%
Immunocompetent Cell
20%
P16
20%
Immunofluorescence
20%
Next Generation Sequencing
20%
CD8
20%
TSC1
20%
Immunogenicity
20%
FOXP3
20%
Human Papillomavirus Type 51
20%
KMT2A
20%
Cyclin Dependent Kinase Inhibitor 2A
20%
Medicine and Dentistry
Head and Neck Squamous Cell Carcinoma
100%
Wart Virus
100%
Brain Metastasis
100%
Programmed Death-Ligand 1
100%
Tumor
25%
Ligation
25%
Next Generation Sequencing
12%
Overall Survival
12%
Immunotherapy
12%
Immunofluorescence
12%
Immunocompetent Cell
12%
P16
12%
CD8 Antigen
12%
Immunogenicity
12%
Cyclin Dependent Kinase Inhibitor 2A
12%
Human Papillomavirus Type 51
12%
KMT2A
12%
Immunology and Microbiology
Squamous Cell
100%
Neck
100%
Wart Virus
100%
Programmed Death-Ligand 1
100%
CD8
20%
Immunocompetent Cell
20%
Immunotherapy
20%
Overall Survival
20%
Immunofluorescence
20%
Immunogenicity
20%
FOXP3
20%
Human Papillomavirus Type 51
20%
Next Generation Sequencing
20%